| payload |
{"created_at":"2026-04-10T13:12:08.706 {"created_at":"2026-04-10T13:12:08.706840+00:00","signal_type":"discovery_ipo_delta","source":"discovery_ingestor","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOWFlYMEktV24zdy0tbGM2bGh0Rk5ua19iYWpOU2lUWTFIV21iVDlfUHM3WUdBRnh6ZG5OaGRSbUJMVmt0QjMyRVEyd09UVXpial9pdXBFNlJHd2tTdHpQeUQwQzV6b1Byck9xVzNySEQ0SVZrVDVFc2NBVTE4ZUNUejhsYXlUcFFwbU9nTWFtaGExU2FrbDdyYjhUMS0yOUlfSVcwVWRwTV80akU0NFBPYWkwU3k?oc=5","value":{"fp":"6d754b545f32df68","kind":"ipo_calendar","published_at":"2026-04-10T12:33:03+00:00","source":"BioXconomy","summary":"Avalyn Pharma eyes IPO to fund Phase III trials of inhaled respiratory drugs BioXconomy","tickers":[],"title":"Avalyn Pharma eyes IPO to fund Phase III trials of inhaled respiratory drugs - BioXconomy","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOWFlYMEktV24zdy0tbGM2bGh0Rk5ua19iYWpOU2lUWTFIV21iVDlfUHM3WUdBRnh6ZG5OaGRSbUJMVmt0QjMyRVEyd09UVXpial9pdXBFNlJHd2tTdHpQeUQwQzV6b1Byck9xVzNySEQ0SVZrVDVFc2NBVTE4ZUNUejhsYXlUcFFwbU9nTWFtaGExU2FrbDdyYjhUMS0yOUlfSVcwVWRwTV80akU0NFBPYWkwU3k?oc=5"}}... |